Invention:
This invention is a system and method to quantify optimal CPR through the use of FDA-approved BioStamp wearable sensors. This system will monitor and provide feedback to the CPR provider if CPR is being performed correctly, allowing the CPR provider to make corrections and standardizing the way to individuals are trained in CPR.
Background:
Results of a study of 67 cardiac arrest patients receiving CPR at the University of Chicago hospitals concluded that 28% of intervals were too slow, 40% of compressions were too shallow, and 60% of the patients hyperventilated. CPR doubles a patient's chance of surviving cardiac arrest outside the hospital. Currently, subjective measures on force, pressure, and frequency are used during CPR. This represents a need to quantify what is a proper CPR procedure and provide immediate feedback to the provider.
Applications:
- Hospitals
- Clinics
- Emergency medicine
- Pharmacies
- Urgent care
Advantages:
- Produces quantifiable results
- Provides feedback for adjustment during CPR procedure
- Robust monitoring system
Status: issued U.S. patent #11,298,290
